Continues disclosers for events transected and approved with requisite majority of member in 43rd AGM

MEDI-CAPS LIMITED CIN: L70100MP1983PLC002231 MCL/SE/2026-2027 Date: 23rd September 2026 Online filing at: www.listing.bseindia.com The General Manager, DCS-CRD BSE Limited Rotunda Building, P.J. Tower, Dalal Street, Fort MUMBAI - 400001 Subject: Continuous Disclosure of material events or information under Regulation 30 read with sub-clause 7 of Para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015 as amended from time to time. Reference: Medi-Caps Limited (BSE Scrip Code: 523144, ISIN: INE442D01010) Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) and with reference to SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 regarding Continuous Disclosure requirement for Listed Entities; we are enclosing following events which were transacted and approved with requisite majority by members in 43rd Annual General Meeting of the Company held on 22nd September, 2026 for which disclosure as required under Sub Para A of Part A of Schedule III required: 1. Confirmation of Re-appointment of Mr. Alok K Garg (DIN: 00274321), Chairman and Managing Director of the Company and Payment of Remuneration. 2. Confirmation of appointment of Mrs. Saloni Garg (DIN: 11865402) as a Director as well as Whole-Time Woman Director of the Company. Details required under Regulation 30 of the SEBI Listing Regulations read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-PoD2/I/3762/2026 dated January 30, 2026 is enclosed herewith as “Annexure-A”. Further, aforesaid disclosure shall also be available on the website of the Company at www.medicaps.com and shall also be submitted in XBRL mode within prescribed time limit. The 43rd Annual General Meeting of the Company held on Tuesday, 22nd September, 2026 commenced at 12.30 P.M. and concluded at 12.50 P.M. However, a combined scrutinizer report was received on Wednesday, September 23, 2026 from the scrutinizer. REGISTERED OFFICE 201, PUSHPRATNA PARADISE, 9/5 NEW PALASIYA INDORE – 452001 PH:- 0731-4028148, FAX:- 0731-4041435 E mail:- investors@medicaps.com, Web site:- www.medicaps.com MEDI-CAPS LIMITED CIN: L70100MP1983PLC002231 You are requested to take the above information for your reference and record. Thanking you, Yours Faithfully, FOR, MEDI-CAPS LIMITED ABHISHEK JAIN COMPANY SECRETARY & COMPLIANCE OFFICER M. No. A36699 REGISTERED OFFICE 201, PUSHPRATNA PARADISE, 9/5 NEW PALASIYA INDORE – 452001 PH:- 0731-4028148, FAX:- 0731-4041435 E mail:- investors@medicaps.com, Web site:- www.medicaps.com MEDI-CAPS LIMITED CIN: L70100MP1983PLC002231 ANNEXURE-A CONTINUOUS DISCLOSURE UNDER SUB-PARA 7 OF PARA A OF PART A OF SCHEDULE III PURSUANT TO REGULATION 30 OF THE SEBI (LODR) REGULATION, 2015 (CONFIRMATION OF APPOINTMENT OF WHOLE TIME DIRECTOR, RE- APPOINTMENT OF CHAIRMAN AND MANAGING DIRECTOR OF THE COMPANY) Disclosure Mr. Alok K Garg Mrs. Saloni Garg S. No. Requirement 01 Reason for change Confirmation of members Confirmation of members be viz., appointment, re- be and are hereby obtained and are hereby obtained in the appointment, in the 43rd Annual General 43rd Annual General Meeting resignation, removal, Meeting held on 22nd held on 22nd September, 2026 death or otherwise September, 2026 for Re- for appointment of Mrs. Saloni Appointment of Mr. Alok K Garg (DIN: 11865402) as a Garg (DIN: 00274321) as Director as well as Whole Chairman and Managing Time Woman Director of the Director. company. 02 Date of Date of re-appointment with Appointed Director as well as appointment/re- effect from 01st September, Whole-Time Woman Director appointment/cessation 2026 and confirmation of w.e.f. 07th August, 2026 and members obtained in 43rd confirmation of members Annual General Meeting obtained in 43rd Annual held on 22nd September, General Meeting held on 22nd 2026. September, 2026. 03 Term of For a period of 3 (Three) For a period of 3 (Three) years Appointment/Re- years w.e.f. 01st September, w.e.f. 07th August, 2026 to 06th Appointment 2026 to 31st August, 2029 August, 2029 04 Brief profile (in case Mr. Alok Garg is a Mrs. Saloni Garg has of appointment) Bachelor of Business completed Graduate in Administration (Honors) Business Management from and Master in Business Mumbai and Masters in Brand Administration (Marketing) Management from Italy. also hold Diploma in Export She has experience as a Documentation & Freelance Brand Manager and Implementation from The helping businesses find their Indian Institute of Foreign identity, brand logos, websites, REGISTERED OFFICE 201, PUSHPRATNA PARADISE, 9/5 NEW PALASIYA INDORE – 452001 PH:- 0731-4028148, FAX:- 0731-4041435 E mail:- investors@medicaps.com, Web site:- www.medicaps.com MEDI-CAPS LIMITED CIN: L70100MP1983PLC002231 Trade, Delhi. He has more communication design and than 26 years’ experience in also having vast experience of the field of pharma industry day to day workings of an and real estate sector. organization to ensure efficient performance. 05 Disclosure of Mr. Alok K. Garg is the Mrs. Saloni Garg is the relationships between Father-in-law of Mrs. Daughter-in-law of Mr. Alok directors (in case of Saloni Garg, Whole-time K. Garg, Chairman and appointment of a Woman Director of the Managing Director of the director) Company. Company. Further the Company would like to bring to your notice that SEBI Letter dated June 14, 2018 read with Circular No. LIST/COMP/14/2018-19 issued by BSE, requires Listed Companies to ensure that the person proposed to be appointed as “Director” shall not be debarred from holding the office by virtue of any SEBI Order or any other authority. We would like to confirm that Mr. Alok K Garg (DIN: 00274321) who has been re-appointed as “Chairman and Managing Director” and Mrs. Saloni Garg (DIN: 11865402) who has been appointed as an “Director and Whole Time Woman Director” of the company, are not debarred from holding office of Director by virtue of SEBI order or any other authority. Further neither SEBI nor any other authority has passed any order against them restricting their ability to act as a Director of the Company. The 43rd Annual General Meeting of the Company held on Tuesday, 22nd September, 2026 commenced at 12.30 P.M. and concluded at 12.50 P.M. However, a combined scrutinizer report was received on Wednesday, September 23, 2026 from the scrutinizer. FOR MEDI-CAPS LIMITED ABHISHEK JAIN COMPANY SECRETARY & COMPLIANCE OFFICER M.N. A36699 REGISTERED OFFICE 201, PUSHPRATNA PARADISE, 9/5 NEW PALASIYA INDORE – 452001 PH:- 0731-4028148, FAX:- 0731-4041435 E mail:- investors@medicaps.com, Web site:- www.medicaps.com